Discover a study revealing how prebiotics improve acne vulgaris by balancing the skin microbiome and enhancing collagen for ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study titled ‘A Phase 1, Randomized, ...
Kane Biotech (($TSE:KNE)) announced an update on their ongoing clinical study. Kane Biotech Inc., in collaboration with the University of Miami, ...
The tea: This facial treatment typically includes a cleanse, signature micropeel and manual extractions, but it can also be ...
NICE is unable to make a recommendation on clascoterone (Winlevi) for treating acne vulgaris in people 12 years and over. This is because the company did not provide an evidence submission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback